Registry-listed formulations

Muscimol · mesh:M0014231

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Completion Rate
    0%(0/1)
    Active Trials
    0(0%)
    Terminated
    1(50%)

    Phase Distribution

    Phase 1
    2
    100%

    Phase Distribution

    2

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 1Safety & dosage
    2(100.0%)

    Highest Phase Reached

    Phase 1

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 2 finished

    Non-Completion Rate

    100.0%

    2 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Terminated(2)

    Detailed Status

    Terminated1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    0.0%
    Most Advanced
    Phase 1

    Trials by Phase

    Phase 12 (100.0%)

    Trials by Status

    terminated150%
    withdrawn150%

    Recent Activity

    Clinical Trials (2)

    Drug Details

    Intervention Type
    Drug
    Molecule Type
    Small molecule
    Total Trials
    2

    External References